IMMUNIC, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

IMMUNIC, INC. reported Cash And Cash Equivalents At Carrying Value of $15.48 million for the year ending 2025.

  • IMMUNIC, INC. showed a decrease of -56.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $6.15 million | Q2 2013: $36.44 million | Q3 2013: $31.16 million | Q1 2014: $46.04 million | Q2 2014: $90.84 million | Q3 2014: $79.09 million | Q1 2015: $88.26 million | Q2 2015: $71.95 million | Q3 2015: $59.75 million | Q1 2016: $77.88 million | Q2 2016: $73.60 million | Q3 2016: $68.09 million | Q1 2017: $86.64 million | Q2 2017: $76.15 million | Q3 2017: $66.39 million | Q4 2017: $56.90 million | Q1 2018: $43.65 million | Q2 2018: $31.12 million | Q3 2018: $17.80 million | Q1 2019: $7.59 million | Q2 2019: $36.12 million | Q3 2019: $30.46 million | Q1 2020: $18.58 million | Q2 2020: $48.61 million | Q3 2020: $133.18 million | Q1 2021: $114.84 million | Q2 2021: $87.18 million | Q3 2021: $110.44 million | Q1 2022: $95.71 million | Q2 2022: $88.08 million | Q3 2022: $72.77 million | Q1 2023: $92.76 million | Q2 2023: $77.29 million | Q3 2023: $59.69 million | Q1 2024: $97.31 million | Q2 2024: $79.70 million | Q3 2024: $59.07 million | Q1 2025: $14.30 million | Q2 2025: $55.31 million | Q3 2025: $35.13 million.
  • Over the full 15 years of available data (2011 to 2025), IMMUNIC, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 1,828.1%.
  • Historical annual values: Fiscal year 2025: $15.48 million | Fiscal year 2024: $35.67 million | Fiscal year 2023: $46.67 million | Fiscal year 2022: $106.75 million | Fiscal year 2021: $86.86 million | Fiscal year 2020: $127.45 million | Fiscal year 2019: $29.37 million | Fiscal year 2018: $13.07 million | Fiscal year 2017: $56.90 million | Fiscal year 2016: $59.99 million | Fiscal year 2015: $83.42 million | Fiscal year 2014: $102.24 million | Fiscal year 2013: $38.19 million | Fiscal year 2012: $4.48 million | Fiscal year 2011: $803.0 thousand.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: